These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


310 related items for PubMed ID: 20599473

  • 1. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
    Wang L, Sato H, Zhao S, Tooyama I.
    Neurosci Lett; 2010 Sep 13; 481(3):164-7. PubMed ID: 20599473
    [Abstract] [Full Text] [Related]

  • 2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 13; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 3. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.
    Acta Neuropathol; 2008 Oct 01; 116(4):409-18. PubMed ID: 18679696
    [Abstract] [Full Text] [Related]

  • 5. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.
    Neurobiol Aging; 2004 Aug 01; 25(7):861-71. PubMed ID: 15212840
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M.
    J Neuropathol Exp Neurol; 2007 Jun 01; 66(6):469-80. PubMed ID: 17549007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL.
    J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807
    [Abstract] [Full Text] [Related]

  • 11. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul 04; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 12. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W, Goldhammer S, Bauer U, Wegner F, Wirths O, Bayer TA, Grosche J.
    J Chem Neuroanat; 2010 Sep 04; 40(1):82-92. PubMed ID: 20347032
    [Abstract] [Full Text] [Related]

  • 13. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun 04; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
    Stahl T, Reimers C, Johne R, Schliebs R, Seeger J.
    Eur J Neurosci; 2006 Oct 04; 24(7):1923-34. PubMed ID: 17067295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP.
    Neurobiol Dis; 2006 Dec 04; 24(3):516-24. PubMed ID: 17029828
    [Abstract] [Full Text] [Related]

  • 19. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY, Friedman JE, Angel I, Kozak A, Koh JY.
    Neurobiol Aging; 2004 Dec 04; 25(10):1315-21. PubMed ID: 15465629
    [Abstract] [Full Text] [Related]

  • 20. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.